Sign in
4

Changes in Ownership

BioAge Labs, Inc. Filed Acc 0001210905-26-000002

Chief Medical Officer sold 7,433 shares at $12.85 ($95,490)

  • Chief Medical Officer acquired 7,433 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

RUBIN PAUL D · Chief Medical Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-01-02 Exercise or conversion : show line 1 in the form 10b5-1 +5,433 $4.11 $22,330 5,433 D
2026-01-02 Exercise or conversion : show line 2 in the form 10b5-1 +2,000 $6.57 $13,140 7,433 D
2026-01-02 Sale : show line 3 in the form 10b5-1 −7,433 $12.85 $95,490 0 D
Open-market sales · 7,433 sh · avg $12.85 · $95,490

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-01-02 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) −5,433 16,303 D
2026-01-02 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) −2,000 7,383 D
Loading xslF345X05/form4-01062026_090157.xml…